UK MHRA issues alert on 'small risk' of Guillain-Barré syndrome with RSV vaccines

4 hours ago 2
Human respiratory syncytial virus inoculation

Hailshadow

  • The UK's Medicines & Healthcare products Regulatory Agency has issued a drug safety update regarding a "small risk" of Guillain-Barré syndrome associated with individuals who have received respiratory syncytial virus (RSV) vaccines made by GSK (NYSE:GSK) and Pfizer (NYSE:PFE).
  • The

Recommended For You

More Trending News

Read Entire Article